STAT+: Moderna touts research progress as it cuts R&D spending by $1.1 billion
Moderna said Thursday it would cut its annual spending on research and development by 23%,…
Category: Moderna
STAT+: Cardiovascular startup raises $260 million led by ex-Moderna execs’ new VC fund
Cardurion Pharmaceuticals, a startup that launched seven years ago with shelved cardiovascular drug candidates from…
STAT+: Former Moderna executive launches genome editing company
As chief medical officer of Moderna, Tal Zaks used to be skeptical of genome editing….
STAT+: Moderna says data show its combination Covid-flu vaccine generates a strong immune response
Moderna announced Monday that, in a Phase 3 clinical trial, its combination Covid-19 and influenza…
STAT+: Moderna ends collaboration with CRISPR company Metagenomi, parts ways with gene editing chief
Three years ago, Moderna, flush with cash from Covid vaccine sales, announced it would start…
STAT+: During the pandemic, were great vaccines bad business? A company-by-company review
It’s been four years since Covid-19 emerged, igniting a pandemic that killed millions of people…
STAT+: Drug development was once a marathon. New tools and timelines are turning it into a sprint
Drug development is more of a sprint than a marathon these days, thanks to more…
Is the flu shot market a slam dunk for mRNA vaccines? Experts aren’t so sure
Here are two things that are true. The world needs more effective flu vaccines. And…
Stéphane Bancel, Bernie Sanders spar over what Moderna owes the federal government
WASHINGTON — Moderna CEO Stéphane Bancel and Senate health committee Chair Bernie Sanders shook hands…